428 related articles for article (PubMed ID: 31402532)
1. Incidence, risk factors, and outcome of pulmonary invasive fungal disease after respiratory virus infection in allogeneic hematopoietic stem cell transplantation recipients.
Piñana JL; Gómez MD; Montoro J; Lorenzo I; Pérez A; Giménez E; González-Barberá EM; Carretero C; Guerreiro M; Salavert M; Sanz G; Hernández-Boluda JC; Borrás R; Sanz J; Solano C; Navarro D
Transpl Infect Dis; 2019 Oct; 21(5):e13158. PubMed ID: 31402532
[TBL] [Abstract][Full Text] [Related]
2. Community-acquired respiratory virus lower respiratory tract disease in allogeneic stem cell transplantation recipient: Risk factors and mortality from pulmonary virus-bacterial mixed infections.
Piñana JL; Gómez MD; Pérez A; Madrid S; Balaguer-Roselló A; Giménez E; Montoro J; González EM; Vinuesa V; Moles P; Hernández-Boluda JC; Salavert M; Calabuig M; Sanz G; Solano C; Sanz J; Navarro D
Transpl Infect Dis; 2018 Aug; 20(4):e12926. PubMed ID: 29809298
[TBL] [Abstract][Full Text] [Related]
3. The effect of timing on community acquired respiratory virus infection mortality during the first year after allogeneic hematopoietic stem cell transplantation: a prospective epidemiological survey.
Piñana JL; Pérez A; Montoro J; Hernani R; Lorenzo I; Giménez E; Gómez MD; Guerreiro M; González-Barberá EM; Carretero C; Salavert M; Balaguer-Roselló A; Sanz G; Hernández-Boluda JC; Solano C; Sanz J; Navarro D
Bone Marrow Transplant; 2020 Feb; 55(2):431-440. PubMed ID: 31551521
[TBL] [Abstract][Full Text] [Related]
4. Assessment of immunodeficiency scoring index performance in enterovirus/rhinovirus respiratory infection after allogeneic hematopoietic stem cell transplantation.
Pérez A; Montoro J; Hernani R; Lorenzo I; Hernández-Boluda JC; Giménez E; Gómez MD; Balaguer-Roselló A; Gonzalez-Barberá E; Guerreiro M; Aguilar C; Navarro D; Solano C; Sanz J; Piñana JL
Transpl Infect Dis; 2020 Aug; 22(4):e13301. PubMed ID: 32363665
[TBL] [Abstract][Full Text] [Related]
5. The clinical benefit of instituting a prospective clinical community-acquired respiratory virus surveillance program in allogeneic hematopoietic stem cell transplantation.
Piñana J; Montoro J; Aznar C; Lorenzo I; Gómez MD; Guerreiro M; Carretero C; González-Barberá EM; Balaguer-Roselló A; Sanz R; Salavert M; Navarro D; Sanz MA; Sanz G; Sanz J
J Infect; 2020 Mar; 80(3):333-341. PubMed ID: 31972212
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology, management, and outcome of invasive fungal disease in patients undergoing hematopoietic stem cell transplantation in China: a multicenter prospective observational study.
Sun Y; Meng F; Han M; Zhang X; Yu L; Huang H; Wu D; Ren H; Wang C; Shen Z; Ji Y; Huang X
Biol Blood Marrow Transplant; 2015 Jun; 21(6):1117-26. PubMed ID: 25840339
[TBL] [Abstract][Full Text] [Related]
7. Detection of community-acquired respiratory viruses in allogeneic stem-cell transplant recipients and controls-A prospective cohort study.
Rachow T; Lamik T; Kalkreuth J; Kurze S; Wagner K; Stier P; Hammersen FJ; Rüthrich MM; Winkelmann N; Klink A; Hilgendorf I; Hermann B; Lang S; Hochhaus A; von Lilienfeld-Toal M
Transpl Infect Dis; 2020 Dec; 22(6):e13415. PubMed ID: 32779843
[TBL] [Abstract][Full Text] [Related]
8. Antifungal agents for secondary prophylaxis based on response to initial antifungal therapy in allogeneic hematopoietic stem cell transplant recipients with prior pulmonary aspergillosis.
Liu Q; Lin R; Sun J; Xiao Y; Nie D; Zhang Y; Huang F; Fan Z; Zhou H; Jiang Q; Zhang F; Zhai X; Xu D; Wei Y; Song J; Li Y; Feng R
Biol Blood Marrow Transplant; 2014 Aug; 20(8):1198-203. PubMed ID: 24769013
[TBL] [Abstract][Full Text] [Related]
9. Cytomegalovirus Reactivation Is Associated with Increased Risk of Late-Onset Invasive Fungal Disease after Allogeneic Hematopoietic Stem Cell Transplantation: A Multicenter Study in the Current Era of Viral Load Monitoring.
Yong MK; Ananda-Rajah M; Cameron PU; Morrissey CO; Spencer A; Ritchie D; Cheng AC; Lewin SR; Slavin M
Biol Blood Marrow Transplant; 2017 Nov; 23(11):1961-1967. PubMed ID: 28797778
[TBL] [Abstract][Full Text] [Related]
10. A Retrospective Study of Central Nervous System Invasive Fungal Disease after Allogeneic Stem Cell Transplantation: Risk Factors, Clinical Characteristics, and Outcomes.
Sun YQ; Liu ZY; Huang XJ; Yan CH; Xu LP; Zhang XH; Liu KY; Wang Y
Biol Blood Marrow Transplant; 2017 Jul; 23(7):1158-1164. PubMed ID: 28390982
[TBL] [Abstract][Full Text] [Related]
11. Validation of a multivariable prediction model for post-engraftment invasive fungal disease in 465 adult allogeneic hematopoietic stem cell transplant recipients.
Rodríguez-Veiga R; Montesinos P; García E; Boluda B; Rojas R; Serrano J; Martínez-Cuadrón D; Martín C; Sanz J; Tabares S; Piñana JL; Lorenzo I; Montoro J; Salavert M; Pemán J; Jarque I; Solves P; Sanz GF; Torres A; Sanz MA
Mycoses; 2019 May; 62(5):418-427. PubMed ID: 30633829
[TBL] [Abstract][Full Text] [Related]
12. Invasive fungal disease is associated with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplant: a single center, retrospective study.
Jin H; Fan Z; Huang F; Chai Y; Xuan L; Lin R; Xu N; Ye J; Sun J; Liu Q
Infection; 2019 Apr; 47(2):275-284. PubMed ID: 30734248
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology and Risk Factors for Invasive Fungal Diseases among Allogeneic Hematopoietic Stem Cell Transplant Recipients in Korea: Results of "RISK" Study.
Choi JK; Cho SY; Yoon SS; Moon JH; Kim SH; Lee JH; Kim JS; Cheong JW; Jang JH; Seo BJ; Kim YJ; Lee HJ; Lee J; Lee JW; Lee DG
Biol Blood Marrow Transplant; 2017 Oct; 23(10):1773-1779. PubMed ID: 28668492
[TBL] [Abstract][Full Text] [Related]
14. Clinical Effectiveness of Influenza Vaccination After Allogeneic Hematopoietic Stem Cell Transplantation: A Cross-sectional, Prospective, Observational Study.
Piñana JL; Pérez A; Montoro J; Giménez E; Gómez MD; Lorenzo I; Madrid S; González EM; Vinuesa V; Hernández-Boluda JC; Salavert M; Sanz G; Solano C; Sanz J; Navarro D
Clin Infect Dis; 2019 May; 68(11):1894-1903. PubMed ID: 30239624
[TBL] [Abstract][Full Text] [Related]
15. Seasonal Human Coronavirus Respiratory Tract Infection in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation.
Piñana JL; Xhaard A; Tridello G; Passweg J; Kozijn A; Polverelli N; Heras I; Perez A; Sanz J; Berghuis D; Vázquez L; Suárez-Lledó M; Itäla-Remes M; Ozcelik T; Iturrate Basarán I; Karakukcu M; Al Zahrani M; Choi G; Cuesta Casas MA; Batlle Massana M; Viviana A; Blijlevens N; Ganser A; Kuskonmaz B; Labussière-Wallet H; Shaw PJ; Yegin ZA; González-Vicent M; Rocha V; Ferster A; Knelange N; Navarro D; Mikulska M; de la Camara R; Styczynski J
J Infect Dis; 2021 May; 223(9):1564-1575. PubMed ID: 32860509
[TBL] [Abstract][Full Text] [Related]
16. Incidence and outcome of invasive fungal diseases after allogeneic hematopoietic stem cell transplantation: A Swiss transplant cohort study.
Kuster S; Stampf S; Gerber B; Baettig V; Weisser M; Gerull S; Medinger M; Passweg J; Schanz U; Garzoni C; Berger C; Chalandon Y; Mueller NJ; van Delden C; Neofytos D; Khanna N;
Transpl Infect Dis; 2018 Dec; 20(6):e12981. PubMed ID: 30144374
[TBL] [Abstract][Full Text] [Related]
17. Characteristics comparisons of bacteremia in allogeneic and autologous hematopoietic stem cell-transplant recipients with levofloxacin prophylaxis and influence on resistant bacteria emergence.
Wang CH; Chang FY; Chao TY; Kao WY; Ho CL; Chen YC; Dai MS; Chang PY; Wu YY; Lin JC
J Microbiol Immunol Infect; 2018 Feb; 51(1):123-131. PubMed ID: 27103500
[TBL] [Abstract][Full Text] [Related]
18. Posaconazole oral suspension for secondary antifungal prophylaxis in allogeneic stem cell transplantation recipients: a retrospective study.
Ye P; Pei R; Hu Y; Chen D; Li S; Cao J; Li F; Wu M; Fang Y; Lu Y
BMC Infect Dis; 2022 May; 22(1):465. PubMed ID: 35570276
[TBL] [Abstract][Full Text] [Related]
19. Comparison of long-term and short-term administration of itraconazole for primary antifungal prophylaxis in recipients of allogeneic hematopoietic stem cell transplantation: a multicenter, randomized, open-label trial.
Lin R; Xu X; Li Y; Sun J; Fan Z; Jiang Q; Huang F; Zhou H; Nie D; Guo Z; Mao Y; Xiao Y; Liu Q
Transpl Infect Dis; 2014 Apr; 16(2):286-94. PubMed ID: 24593273
[TBL] [Abstract][Full Text] [Related]
20. Incidence and characteristics of invasive fungal diseases in allogeneic hematopoietic stem cell transplant recipients: a retrospective cohort study.
Harrison N; Mitterbauer M; Tobudic S; Kalhs P; Rabitsch W; Greinix H; Burgmann H; Willinger B; Presterl E; Forstner C
BMC Infect Dis; 2015 Dec; 15():584. PubMed ID: 26715563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
